Meridian Bioscience | VIVO - Ebit

Meridian Bioscience reported $8.96M in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebit Change
Abbott ABT:US USD 1.64B 135M
Accelerate Diagnostics AXDX:US USD -14961000 3.03M
Atrion ATRI:US USD 8.8M 2.22M
Becton, Dickinson and BDX:US USD 672M 3M
Bio Rad Laboratories BIO:US USD 118.97M 21.58M
Cerus CERS:US USD -9951000 2.5M
Myriad Genetics MYGN:US USD -46000000 1000K
Neogen NEOG:US USD 17.74M 2.02M
Orasure Technologies OSUR:US USD 13.28M 5.85M
Quidel QDEL:US USD 112.9M 29.7M
Rockwell Medical RMTI:US USD -3708000 774K
Sientra SIEN:US USD -12558000 3.38M
Staar Surgical STAA:US USD 964K 12.74M
Thermo Fisher Scientific TMO:US USD 1.92B 156M
Utah Medical Products UTMD:US USD 5.14M 84K